132 related articles for article (PubMed ID: 1675036)
21. [Esmolol in anesthesiology: pharmacology and indications].
Fita G; Gomar C; Rovira I
Rev Esp Anestesiol Reanim; 1999 Nov; 46(9):404-14. PubMed ID: 10613078
[TBL] [Abstract][Full Text] [Related]
22. Esmolol, the first ultra-short-acting intravenous beta blocker for use in critically ill patients.
Blanski L; Lutz J; Laddu A
Heart Lung; 1988 Jan; 17(1):80-9. PubMed ID: 3276651
[TBL] [Abstract][Full Text] [Related]
23. Failure of adjuvant heparin to reduce myocardial ischemia in the early treatment of patients with unstable angina.
Wallis DE; Boden WE; Califf R; Crawford MH; Hakki AH; Iskandrian AS; Labovitz A; O'Connor C; Sutton R; Scanlon PJ
Am Heart J; 1991 Oct; 122(4 Pt 1):949-54. PubMed ID: 1681722
[TBL] [Abstract][Full Text] [Related]
24. The effect of an infusion of esmolol on the incidence of myocardial ischaemia during tracheal extubation following coronary artery surgery.
Kurian SM; Evans R; Fernandes NO; Sherry KM
Anaesthesia; 2001 Dec; 56(12):1163-8. PubMed ID: 11736772
[TBL] [Abstract][Full Text] [Related]
25. Managing critically ill patients with esmolol. An ultra short-acting beta-adrenergic blocker.
Gray RJ
Chest; 1988 Feb; 93(2):398-403. PubMed ID: 2892647
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and Pharmacodynamics of Low-, Intermediate-, and High-Dose Landiolol and Esmolol During Long-Term Infusion in Healthy Whites.
Krumpl G; Ulč I; Trebs M; Kadlecová P; Hodisch J; Maurer G; Husch B
J Cardiovasc Pharmacol; 2018 Mar; 71(3):137-146. PubMed ID: 29112591
[TBL] [Abstract][Full Text] [Related]
27. The effect of single bolus dose of esmolol for controlling the tachycardia and hypertension during laryngoscopy and tracheal intubation.
Yuan L; Chia YY; Jan KT; Chen CS; Wang CH; Haung LH; Kang L
Acta Anaesthesiol Sin; 1994 Sep; 32(3):147-52. PubMed ID: 7921858
[TBL] [Abstract][Full Text] [Related]
28. Esmolol hydrochloride: an ultrashort-acting, beta-adrenergic blocking agent.
Angaran DM; Schultz NJ; Tschida VH
Clin Pharm; 1986 Apr; 5(4):288-303. PubMed ID: 2871961
[TBL] [Abstract][Full Text] [Related]
29. Comparison of esmolol and nitroprusside for acute post-cardiac surgical hypertension.
Gray RJ; Bateman TM; Czer LS; Conklin C; Matloff JM
Am J Cardiol; 1987 Apr; 59(8):887-91. PubMed ID: 2881481
[TBL] [Abstract][Full Text] [Related]
30. Esmolol cardioplegia in unstable coronary revascularisation patients. A randomised clinical trial.
Rinne T; Harmoinen A; Kaukinen S
Acta Anaesthesiol Scand; 2000 Jul; 44(6):727-32. PubMed ID: 10903017
[TBL] [Abstract][Full Text] [Related]
31. Intravenous esmolol is well tolerated in elderly patients with heart failure in the early phase of non-ST elevation myocardial infarction.
Koutouzis M; Nikolidakis S; Grigoriadis A; Koutsogeorgis D; Kyriakides ZS
Drugs Aging; 2006; 23(8):673-80. PubMed ID: 16964989
[TBL] [Abstract][Full Text] [Related]
32. The effect of esmolol on ST-segment depression and arrhythmias after electroconvulsive therapy.
Zvara DA; Brooker RF; McCall WV; Foreman AS; Hewitt C; Murphy BA; Royster RL
Convuls Ther; 1997 Sep; 13(3):165-74. PubMed ID: 9342132
[TBL] [Abstract][Full Text] [Related]
33. Controlled beta-receptor blockade with esmolol and flestolol.
Murthy VS; Frishman WH
Pharmacotherapy; 1988; 8(3):168-82. PubMed ID: 2902602
[TBL] [Abstract][Full Text] [Related]
34. Comparison of two esmolol bolus doses on the haemodynamic response and seizure duration during electroconvulsive therapy.
Kovac AL; Goto H; Pardo MP; Arakawa K
Can J Anaesth; 1991 Mar; 38(2):204-9. PubMed ID: 1673645
[TBL] [Abstract][Full Text] [Related]
35. [The hemodynamic effects of a treatment with beta-receptor blockers during coronary surgery. A comparison between acebutolol and esmolol].
Kling D; Boldt J; Zickmann B; Dapper F; Hempelmann G
Anaesthesist; 1990 May; 39(5):264-8. PubMed ID: 1972611
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of esmolol in children.
Wiest DB; Trippel DL; Gillette PC; Garner SS
Clin Pharmacol Ther; 1991 Jun; 49(6):618-23. PubMed ID: 1676357
[TBL] [Abstract][Full Text] [Related]
37. Control of tachycardia and hypertension following coronary artery bypass graft surgery: efficacy and haemodynamic effects of esmolol.
Tempe DK; Mulchandani P; Tandon MS; Mehta N; Tomar AS; Banerjee A; Khanna SK
Indian Heart J; 1999; 51(3):294-300. PubMed ID: 10624069
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of esmolol and fentanyl in controlling increases in heart rate and blood pressure during endotracheal intubation.
Gaubatz CL; Wehner RJ
AANA J; 1991 Feb; 59(1):91-6. PubMed ID: 1672049
[TBL] [Abstract][Full Text] [Related]
39. Intravenous esmolol for the treatment of supraventricular tachyarrhythmia: results of a multicenter, baseline-controlled safety and efficacy study in 160 patients. The Esmolol Research Group.
Am Heart J; 1986 Sep; 112(3):498-505. PubMed ID: 2875641
[TBL] [Abstract][Full Text] [Related]
40. Cardioprotection by opening of the K(ATP) channel in unstable angina. Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil. CESAR 2 investigation. Clinical European studies in angina and revascularization.
Patel DJ; Purcell HJ; Fox KM
Eur Heart J; 1999 Jan; 20(1):51-7. PubMed ID: 10075141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
